This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering

Engineering strategies for TCR and CAR-T cell therapies - WHITEPAPER


Download the exclusive whitepaper

CAR-T and T-cell receptor (TCR) cell therapies are some of the most exciting emerging therapies on the market today, and their engineering strategies are crucial. This whitepaper discusses recent developments in CAR and TCR engineering and the overlap with antibody engineering, including:

  • Companies leading the way in TCR and T cell engineering

  • Novel platforms and enabling technologies

  • Technologies for Engineering CAR T cells

  • Technologies for Engineering TCRs (T cell receptors)

  • Lessons antibody engineers can learn from TCR and CAR T cell engineers

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email

This piece represents the views of the author and not necessarily the views of Informa Connect Life Sciences.

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.